利福昔明在防治奶牛乳房炎中的研究进展
详细信息    查看全文 | 推荐本文 |
  • 作者:林红 ; 张智德 ; 郑莉 ; 王海挺
  • 关键词:利福昔明 ; 干乳期乳房炎 ; 临床应用
  • 中文刊名:ZGNN
  • 英文刊名:China Dairy Cattle
  • 机构:齐鲁动物保健品有限公司;
  • 出版日期:2014-09-20
  • 出版单位:中国奶牛
  • 年:2014
  • 期:No.278
  • 语种:中文;
  • 页:ZGNN201418006
  • 页数:3
  • CN:18
  • ISSN:11-3009/S
  • 分类号:26-28
摘要
利福昔明是一种治疗奶牛干乳期乳房炎的新药,具有独特的抗菌机制和良好的抗菌活性,其抗菌谱广,抗菌活性强,无致畸性、致突变性、致癌性、生殖毒性,适用于乳房局部用药。本文对其理化性质、作用机理、药理毒理性质及临床应用和疗效进行综述,以便兽医工作者全面了解,进而用以指导临床应用。
        
引文
[1]储明星.奶牛乳房炎的危害及其发生规律与防治[J].中国奶牛,1999,4:5-7.
    [2]EUROPEAN PHARMACOPOEIA 7.0,RIFAXIMIN:2859-2860.
    [3]王佩,李玉珍.利福昔明的药理作用和临床应用[J].药物不良反应杂志,2005,5:382-385.
    [4]Vicenzoni G,Ponzoni A,Madinelli R,et al.Sensitivity to Rifaximin of strains of Staphylococcus aureus isolated from 1997to 1999-Comparison between years and calculation of the correlated MIC[J].Obiettivi e Documenti Veterinari,2000,21(6):39-42.
    [5]Linda Tomasinsig,Gennyfer De Conti,Barbara Skerlavaj,et al.Broad-Spectrum Activity against Bacterial Mastitis Pathogens and Activation of Mammary Epithelial Cells Support a Protective Role of Neutrophil Cathelicidins in Bovine Mastitis[J].Infection and Immunity,2010,78(4):1781-1788.
    [6]V Guérin-Faublée,Tardy F,Bouveron C,et al.Antimicrobial susceptibility of Streptococcus species isolated from clinical mastitis in dairy cows[J].International Journal of Antimicrobial Agents,2002,19(3):219-226.
    [7]Venturini AP,Marchi E.In vitro and in vivo evaluation of L/105,a new topical intestinal rifamycin[J].Chemioterapia(Florence),1986,5:257-262.
    [8]Efi Kokkotou,Alan C.Moss,Athanasios Michos,et al.Comparative efficacies of Rifaximin and Vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters[J].Antimicrobial Agents and Chemotherapy,2008,52(3):1121-1126.
    [9]Food and Drug Administration Center for Drug Evaluation and Research.Xifaxan(Rifaximin),2010,NDA 22-554.
    [10]The European Agency for the Evaluation of Medicinal Products,Committee for Veterinary Medicinal Products.Rifaximin,Revised Summary Report,1995,EMEA/MRL/007-REV.
    [11]Borelli G,Bertoli D.Acute,subacute,chronic toxicity and mutagenicity studies of rifaximin(L/105)in rats[J].Chemioterapia(Florence),1986,5:263-267.
    [12]Carmelo Scarpignato,Iva Pelosini.Rifaximin,a Poorly Absorbed Antibiotic:Pharmacology and Clinical Potential[J].Chemotherapy,2005,51(suppl 1):36-66.
    [13]Bertoli D,Borelli G.Teratogenic action of Rifaximin in the rat and rabbit and its effect on perinatal development in the rat[J].Boll Soc Ital Biol Sper,1984,60(5):1079-1085.
    [14]Bertoli D,Borelli G.Fertility study of rifaximin(L/105)in rats[J].Chemioterapia,1986,5(3):204-207.
    [15]ávila-Téllez S,Rivera-Alvarez R.An Evaluation of Therapeutic Efficacy of Rifaximin in Mastitis Control Program at Drying-off and at Calving,in Two Dairy Herds under Field Condition[A].2008,Proceedings of the XXV Jubilee World Buiatrics Congress,Budapest,Hungary.
    [16]Bertocchi L,Varisco G,Farina R.Rifaximin and Cephacetrile in a Control Program for Staphylococcus Aureus Infections in Dairy Herds[A].XXI Worl Buiatric Congress.Uruguay,2000.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.